Capital market regulator Sebi on Monday allowed Fresenius Kabi Oncology to delist its shares from the Indian stock market and asked the healthcare firm to complete the delisting process within three months -- bringing to an end a long-standing dispute.
first published: Jul 22, 2013 11:00 pm
A collection of the most-viewed Moneycontrol videos.
Rupee Rebounds After Crash! RBI’s Big Move Explained | INR vs Dollar Update
Multi Asset Allocation Funds Explained: Balance Risk, Returns & Volatility in Any Market
Indian market & Rupee see sharp recovery | Brent Oil up 5% | Global markets fall on geopolitical risk
Trump Mocks Macron Again, Criticizes NATO Allies Terming Alliance 'Paper Tiger'
